Toxoplasma gondii and ovine toxoplasmosis: new aspects of an old story

Ovine toxoplasmosis, caused by the intracellular protozoan parasite Toxoplasma gondii, was first described in 1954 and while the incidence of ovine infection is difficult to define, it has been reported that in the UK it is responsible for between 1 and 2% of neonatal losses per annum. Recent reports have suggested that sheep persistently infected with T. gondii may pass infection to the fetus in subsequent pregnancies more readily than previously thought. These data show a high proportion of both successful and failed pregnancies in sheep to be positive by PCR for T. gondii with a tendency for samples from certain genetic lines of Charollais sheep more likely to be positive than samples from other lines, suggesting that some sheep have a particular genetic susceptibility to T. gondii.     

Nasopharyngeal trichobezoar foreign body in a cat

CASE SUMMARY: A 5-year-old male neutered indoor cat presented for evaluation and treatment of an acute onset of nasal discharge and open-mouth breathing of 3 days' duration. He had been treated for asthma prior to presentation, but his clinical signs were more consistent with upper airway disease. Thoracic radiographs were suggestive of asthma. However, a soft tissue mass was noted in the nasopharynx on a lateral cervical radiograph. Nasopharyngeal examination revealed the mass to be a trichobezoar (hair ball) lodged in the nasopharynx, removal of which led to resolution of clinical signs. The cat re-presented with a second nasopharyngeal trichobezoar approximately 1 year later, which was also successfully removed. CLINICAL SIGNIFICANCE: Nasopharyngeal disease has myriad potential infectious, inflammatory and neoplastic etiologies. However, simpler causes such as foreign bodies can be considered in cases of acute-onset nasopharyngeal disease. To the authors' knowledge, this is the first reported case of a nasopharyngeal trichobezoar foreign body in a cat.     

Efficacy of extended pirlimycin therapy for treatment of experimentally induced Streptococcus uberis intramammary infections in lactating dairy cattle

Streptococcus uberis is an important cause of mastitis in dairy cows throughout the world, particularly during the dry period, around the time of calving, and during early lactation. Strategies for controlling S. uberis mastitis have not received adequate research attention and are therefore poorly defined and inadequate. Objectives of the present study were to evaluate the efficacy of extended therapy regimens with pirlimycin for treatment of experimentally induced S. uberis intramammary infections in lactating dairy cows during early lactation and to evaluate the usefulness of the S. uberis experimental infection model for evaluating antimicrobial efficacy in dairy cows. The efficacy of extended pirlimycin intramammary therapy regimens was investigated in 103 mammary glands of 68 dairy cows that became infected following experimental challenge with S. uberis during early lactation. Cows infected with S. uberis in one or both experimentally challenged mammary glands were randomly allocated to three groups, representing three different treatment regimens with pirlimycin, including 2-day (n = 21 cows, 31 mammary quarters), 5-day (n = 21 cows, 32 quarters), and 8-day (n = 26 cows, 40 quarters). For all groups, pirlimycin was administered at a rate of 50 mg of pirlimycin hydrochloride via intramammary infusion. A cure was defined as an experimentally infected mammary gland that was treated with pirlimycin and was bacteriologically negative for the presence of S. uberis at 7, 14, 21, and 28 days after treatment. Experimental S. uberis intramammary infections were eliminated in 58.1% of the infected quarters treated with the pirlimycin 2-day regimen, 68.8% for the 5-day regimen, and 80.0% for the 8-day regimen. Significant differences (P <.05) in efficacy were observed between the 2-day and 8-day treatment regimens. The number of somatic cells in milk decreased significantly following therapy in quarters for which treatment was successful in eliminating S. uberis. However, there was no evidence to suggest that extended therapy with pirlimycin resulted in a greater reduction in somatic cell counts in milk than the 2-day treatment. The S. uberis experimental infection model was a rapid and effective means of evaluating antimicrobial efficacy during early lactation at a time when mammary glands are highly susceptible to S. uberis intramammary infection.     

The effects of femoral stem and neck length on cement strains in a canine total hip replacement model

OBJECTIVE: To determine the effects of femoral prosthesis stem length and head size on cement strains in a canine hip replacement system. STUDY DESIGN: An in vitro experimental model. SAMPLE POPULATION: (1) Three standard and 3 1-cm shortened femoral implants with +3 femoral heads. (2) Two standard implants with +0, +3, and +6 femoral heads. METHODS: Femoral stems were embedded in polymethylmethacrylate cement. A uniaxial proximodistal-oriented strain gauge was applied to the cement on the medial and lateral aspects of the construct 1.5 cm, 6.0 cm and 7.0 cm distal to the collar. Each construct with a +3 femoral head was mounted in a materials testing system. An axial compressive load (0-200 N) was applied to the femoral head and cement strains were recorded. Additionally, 2 standard length constructs were also tested with +0 and +6 femoral heads. The effects of stem length and neck length on cement strains were assessed with analysis of variance. RESULTS: Strains increased at all locations with increasing loads for all constructs. Shorter implants had higher strains by 152% and 171%, lateral (P =.003) and medial (P =.0025) to the stem tip. No significant strain differences were noted, at any strain gauge location, between different neck lengths (P values ranged from.20 to.67). CONCLUSIONS: Although a shorter implant stem has a potential to improve implant fit, it led to significantly higher cement strains that may increase the risk for aseptic loosening. Changes in femoral neck length did not significantly affect cement strains under the conditions tested. CLINICAL RELEVANCE: Shortening of the femoral stem currently cannot be recommended in canine total hip replacement. The existing use of variable neck lengths likely does not increase the risk of failure of the femoral stem.     

Onchocerca sp. in an imported Zangersheide gelding causing suspensory ligament desmitis

A 5-year-old imported Zangersheide gelding was evaluated for SC swellings over both forelimbs and lameness localized to the distal metacarpus. Ultrasound examination of the SC masses was compatible with verminous granulomas. Linear hyperechoic foci were present within the suspensory ligament branches of both forelimbs, suggestive of ligamentous parasitic infiltrates. A diagnosis of onchocerciasis was confirmed on biopsy of a SC mass. The gelding was treated with ivermectin and a tapering course of PO dexamethasone but was eventually euthanized. Necropsy confirmed the presence of SC eosinophilic granulomas and degenerative suspensory ligament desmitis, both with intralesional nematodes. Given the location and appearance of the nematode, a diagnosis of Onchocerca sp., most likely O. reticulata, was made. Onchocerciasis should be included as a differential diagnosis for multifocal suspensory ligament desmitis with these sonographic characteristics when paired with SC masses in imported European Warmbloods.     

In Vitro Mechanical Comparison of 2.0 and 2.4 Limited‐Contact Dynamic Compression Plates and 2.0 Dynamic Compression Plates of Different Thicknesses

Objective: To compare the bending structural stiffness and bending strength of thick and thin 2.4 mm limited contact dynamic compression plates (2.4 LC‐DCP), 2.0 mm LC‐DCP (2.0 LC‐DCP), and 2.0 dynamic compression plates (2.0 DCP). Study Design: In vitro mechanical study. Methods: Two thicknesses of 2.4 LC‐DCP, 2.0 LC‐DCP, and 2.0 DCP stainless‐steel plates were tested in 4‐point bending. Data were collected during bending until implants plastically deformed. Bending structural stiffness and bending strength were determined from load displacement curves. Mechanical properties were compared between plates and the effects of plate type, size, and thickness on stiffness and strength were assessed using ANOVA. Results: The thick 2.4 LC‐DCP implant was the stiffest and strongest; the thin 2.0 DCP implant was most compliant and weakest. Larger sized plates, thicker plates, and limited contact design of plates enhanced stiffness and strength. For the plates studied, plate size had a larger effect than plate type or thickness on stiffness and strength. Conclusion: Increasing the size (width) and thickness of plates increases both the bending structural stiffness and strength. For the plates studied, LC‐DCP implants were stiffer and stronger than DCP implants. Clinical Relevance: Plate bending structural stiffness and strength can be most effectively enhanced by using a larger sized plate, but gains can also be achieved by using a thicker plate and/or an LC‐DCP instead of a DCP implant when possible.